Stockscreener 앱 받기
2.18
4.81%
0.10
시간 외 거래:
2.16
-0.02
-0.92%
전일 마감가:
$2.08
열려 있는:
$2.15
하루 거래량:
675.19K
Relative Volume:
0.40
시가총액:
$75.30M
수익:
$300.00K
순이익/손실:
$-24.74M
주가수익비율:
-2.167
EPS:
-1.006
순현금흐름:
$-19.19M
1주 성능:
-0.46%
1개월 성능:
-24.04%
6개월 성능:
+173.63%
1년 성능:
-50.57%
1일 변동 폭
$2.12
$2.24
1주일 범위
$1.9801
$2.30
52주 변동 폭
$0.5562
$4.74
iBio Inc Stock (IBIO) Company Profile
명칭
iBio Inc
전화
302-355-0650
주소
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
2.18 | 71.85M | 300.00K | -24.74M | -19.19M | -1.006 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Oppenheimer | Outperform |
| 2025-10-17 | 개시 | Leerink Partners | Outperform |
| 2024-05-28 | 개시 | Chardan Capital Markets | Buy |
| 2021-11-29 | 개시 | JMP Securities | Mkt Outperform |
| 2021-01-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-06-26 | 개시 | Alliance Global Partners | Buy |
모두보기
iBio Inc 주식(IBIO)의 최신 뉴스
Panic Selling: Is iBio Inc impacted by rising ratesWeekly Stock Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Insider Buying: Felipe Duran Acquires Shares of iBio Inc (IBIO) - GuruFocus
INB.bio Launches Rebuilt Ai-Powered Affiliate Crm Platform - marketscreener.com
Martin Brenner Purchases 12,336 Shares of iBio (NASDAQ:IBIO) Stock - MarketBeat
iBio (NASDAQ:IBIO) CFO Felipe Duran Acquires 24,835 Shares - MarketBeat
iBio CFO Duran acquired $50k in shares on March 19 - Investing.com
iBio director Brenner buys $24918 in company stock By Investing.com - Investing.com Australia
iBio director Brenner buys $24918 in company stock - Investing.com
IBIO | iBio, Inc. Common Stock Insider Trading - Quiver Quantitative
iBio CFO Duran acquired $50k in shares on March 19 By Investing.com - Investing.com South Africa
CFO adds 24,835 iBio (NYSE: IBIO) shares in open-market purchase - Stock Titan
iBio (IBIO) director makes open-market purchase of 12,336 shares - Stock Titan
Aug Action: Is iBio Inc a speculative investmentTrade Analysis Report & Weekly High Return Forecasts - baoquankhu1.vn
IBIO Technical Analysis | Trend, Signals & Chart Patterns | IBIO INC (NASDAQ:IBIO) - ChartMill
Ibio (IBIO) Receives a Buy from LifeSci Capital - The Globe and Mail
History Review: Can iBio Inc stock double in the next yearTake Profit & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
iBio (NASDAQ:IBIO) Cut to Sell at Wall Street Zen - MarketBeat
Aug Movers: Is iBio Inc impacted by rising rates2026 Earnings Surprises & Weekly Top Stock Performers List - baoquankhu1.vn
iBio Touts Bispecific Antibody Strategy for PH-HFpEF, Eyes Development Candidate in Q3 - MarketBeat
Chardan Capital Maintains IBio Inc(IBIO.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
IBIO: Analyst Keay Nakae Reaffirms 'Buy' Rating with $5.00 Price Target | IBIO Stock News - GuruFocus
Aug Opening: How do insiders feel about iBio IncQuarterly Trade Report & Low Drawdown Trading Strategies - baoquankhu1.vn
Jones Trading reiterates iBio stock rating on pulmonary hypertension expansion By Investing.com - Investing.com South Africa
Jones Trading reiterates iBio stock rating on pulmonary hypertension expansion - Investing.com India
VIX Spike: Is IBIO in a long term uptrend2026 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
iBio (NASDAQ:IBIO) Given Buy Rating at Chardan Capital - MarketBeat
iBio (IBIO) to Discuss Pipeline Expansion in Upcoming Conference Call - GuruFocus
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - The Manila Times
Stop Loss: How sensitive is iBio Inc to inflationWeekly Gains Report & Real-Time Chart Pattern Alerts - baoquankhu1.vn
iBio reports fat reduction in primate obesity study By Investing.com - Investing.com Nigeria
Ibio SEC Filings - Stock Titan
iBio, Inc. (NASDAQ:IBIO) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Highs Report: Is iBio Inc a turnaround storyRate Cut & Reliable Price Action Trade Plans - baoquankhu1.vn
IBIO: Advancing novel antibody therapies for obesity and cardiometabolic disease with strong clinical momentum - TradingView
Jones Trading reiterates iBio stock rating on obesity drug data - Investing.com
Jones Trading reiterates iBio stock rating on obesity drug data By Investing.com - Investing.com UK
iBio Reports Promising Preclinical Results for IBIO-610 Activin E Antibody in Fat-Selective Weight Loss for Obesity and Cardiometabolic Diseases 1 - Minichart
IBIO: Innovative antibody pipeline aims for fat-specific weight loss and muscle preservation in obesity - TradingView
iBio reports fat reduction in primate obesity study - Investing.com
iBio Highlights IBIO-610 Obesity and Cardiometabolic Potential - TipRanks
iBio (IBIO) Reports Promising Preclinical Results for Obesity Tr - GuruFocus
iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss - Bitget
Primate obesity study backs iBio fat-loss antibody, twice-yearly dosing potential - Stock Titan
[EFFECT] iBio, Inc. SEC Filing - Stock Titan
Leerink Partners Maintains IBio Inc(IBIO.US) With Buy Rating, Raises Target Price to $5 - 富途牛牛
Cash per share of iBio, Inc. – MUN:0JV0 - TradingView
IBIO Stock Price, Quote & Chart | IBIO INC (NASDAQ:IBIO) - ChartMill
iBio (NASDAQ:IBIO) Upgraded by JonesTrading to Strong-Buy Rating - MarketBeat
Jones Trading Initiates Coverage of iBio (IBIO) with Buy Recommendation - Nasdaq
JonesTrading Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $7 - 富途牛牛
iBio (IBIO) Receives New 'Buy' Rating from Jones Trading | IBIO Stock News - GuruFocus
iBio Inc (IBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):